High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT. - Hengeveld, M; Suciu, S; Chelgoum, Y; Marie, J-P; Muus, P; Lefrère, F; Mandelli, F; Pane, F; Amadori, S; Fioritoni, G; Labar, B; Baron, F; et al. (Bone Marrow Transplantation, 2015)